Constitutive activation of mutated FLT3 promotes clonal proliferation through multiple downstream signaling pathways like JAK/STAT5 (4, 5), leading to frequent relapse and a very poor prognosis for AML patients (6). This evidence concerns the gene FLT3 and acute myeloid leukemia.